Review of Phase 1 Pharmacodynamic Models to Characterize Botulinum Neurotoxins: Ability to Assess Onset, Duration, Diffusion, and Pain Threshold in Early Clinical Development

Toxicon 2026

View at publisher

Authors: Irene Sunwoo, Sana Khajehpour, Mitalee Tamhane, Jie Shen

DOI: 10.1016/j.toxicon.2025.108881

Cited by: 0

Fields of Study & Subjects

Botulinum Toxin and Related Neurological Disorders Neurological disorders and treatments Pain Mechanisms and Treatments